Ticker Details
Bicara Therapeutics Inc. Common Stock
IPO Date:	September 13, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.44B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.53 | 3.49%
Avg Daily Range (30 D):	$0.45 | 2.38%
Avg Daily Range (90 D):	$0.43 | 2.43%

Institutional Daily Volume
Avg Daily Volume:	.47M
Avg Daily Volume (30 D):	.47M
Avg Daily Volume (90 D):	.43M

Trade Size
Avg Trade Size (Sh.):	71
Avg Trade Size (Sh.) (30 D):	55
Avg Trade Size (Sh.) (90 D):	59

Institutional Trades
Total Institutional Trades:	443
Avg Institutional Trade:	$1.52M
Avg Institutional Trade (30 D):	$1.65M
Avg Institutional Trade (90 D):	$1.72M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.56M
Avg Closing Trade (30 D):	$1.92M
Avg Closing Trade (90 D):	$1.75M
Avg Closing Volume:	101.02K

News

Feb 26, 2026 @ 9:01 PM Bicara Therapeutics Announces Closing of Oversubsc... Source: Globe Newswire

Feb 25, 2026 @ 4:13 AM Bicara Therapeutics Announces Pricing of $150 Mill... Source: Na

Feb 24, 2026 @ 9:01 PM Bicara Therapeutics Announces Proposed Public Offe... Source: Globe Newswire

Dec 15, 2025 @ 1:00 PM Bicara Therapeutics to Present at the J.P. Morgan ... Source: Claire Mazumdar

Dec 6, 2025 @ 1:00 PM Bicara Therapeutics’ Preliminary Phase 1b E... Source: Bicara Therapeutics

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-2.52	$-.68	$-2.52
Diluted EPS	$-2.52	$-.68	$-2.52
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-137.95M	$-37.39M	$-137.95M
Operating Income / Loss	$-155.6M	$-41.12M	$-155.6M
Cost of Revenue
Net Cash Flow	$-393.03M	$-74.99M	$-393.03M
PE Ratio